Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- Long-term tolerability and retention of adjunctive brivaracetam in children <4 years of age with focal seizures: pooled analysis of data from two open-label trials No ClinicalTrials.gov identifier reported
- Long-Term Tolerability and Safety of Immune Globulin Infusion 10 Human With Recombinant Human Hyaluronidase Hyqviahyqvia for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp NCT02955355
- Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (Hyqvia/Hyqvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (Cidp) No ClinicalTrials.gov identifier reported
- Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (Hyqvia/Hyqvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (Cidp) NCT02955355
- Long-Term Tolerability and Safety of Immune Globulin Subcutaneous Igsc Solution Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase Rhuph20 in Subjects With Primary Immunodeficiency Diseases Tolerability and Safety of Immune Globulin Subcutaneous Solution Igsc and Rhuph20 in Pid NCT00814320
- Long-Term Tolerability and Safety of Immune Globulin Subcutaneous Solution Igsc Administered Subcutaneously Following Administration of Recombinant Human Hyaluronidase Rhuph20 in Subjects With Primary Immunodeficiency Diseases NCT01175213
- Long Term Treatment Outcomes of 270 and 360 Degree Labral Tears No ClinicalTrials.gov identifier reported
- Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice No ClinicalTrials.gov identifier reported
- Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) No ClinicalTrials.gov identifier reported
- Long-term Visual and Astigmatic Outcomes of Keratoconus Patients Following Sequential Cross-linking and Custom Topography-Guided Surface Ablation No ClinicalTrials.gov identifier reported
- Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis No ClinicalTrials.gov identifier reported
- Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis NCT05962788
- LOOK AHEAD Association of baseline and longitudinal changes in cardiac biomarkers and risk of cardiovascular disease among adults with type 2 diabetes mellitus a cardiac biomarker ancillary study proposal to the Look AHEAD study No ClinicalTrials.gov identifier reported
- Loose Screw or No Screw? A biomechanical study to answer a common intraoperative dilemma No ClinicalTrials.gov identifier reported
- Loqi No ClinicalTrials.gov identifier reported
- LOQI Impella Registry No ClinicalTrials.gov identifier reported
- Lorlatinib Clinical Publication Program No ClinicalTrials.gov identifier reported
- Lorlatinib Pf06463922 Continuation Protocol An Openlabel Singlearm Continuation Study for Participants With Alkpositive Or Ros1positive Nonsmall Cell Lung Cancer Nsclc Continuing From Pfizer Sponsored Lorlatinib Clinical Studies No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lotrafilcon B Cosmetic Contact Lenses with Refractive Powers Post-Market Clinical Follow-up Study No ClinicalTrials.gov identifier reported
- Lot-to-lot Consistency of 3 Lots of TDV in Non-Endemic Countryies for Dengue No ClinicalTrials.gov identifier reported
- Lot to lot multisite Reproducibility Study No ClinicalTrials.gov identifier reported
- Lotus No ClinicalTrials.gov identifier reported
- Lotus Edge In TAVR A Novel Implant Technique to Minimize Incidence of Post Operative Pacemaker No ClinicalTrials.gov identifier reported
- LOU064C12301 and LOU064C12302 No ClinicalTrials.gov identifier reported
- LOU064C12301 and LOU064C12302 No ClinicalTrials.gov identifier reported
- LOU064C12301 and LOU064C12302 No ClinicalTrials.gov identifier reported
- LOU064C1_Clinical_PM trail No ClinicalTrials.gov identifier reported
- Lou064i2301 No ClinicalTrials.gov identifier reported
- LOU064 I Study No ClinicalTrials.gov identifier reported